小鼠被动免疫抗H5N1 IgY可抵御实验性流感病毒感染并允许形成保护性免疫
研究用鸡抗H5N1 IgY、正常IgY或PBS经鼻给予成年或老年C57BL/6NCrl小鼠(雌雄均有),在H1N1流感病毒(PR8)感染前4小时和感染后20小时给药。结果显示,接受交叉反应性IgY抗H5N1的小鼠受到保护、未发病,并产生与对照小鼠相似的流感病毒特异性记忆T细胞;初次感染后35天再次攻击PR8时完全保护,感染后3个月用异型H3N2(X-31)或PR8攻击时仍免受严重疾病和死亡,仅见轻度一过性体重下降。结论认为,IgY抗H5N1被动免疫安全,可保护小鼠免于流感病毒所致疾病,且不抑制病毒暴露后保护性免疫的形成。
要点
- 抗H5N1 IgY被动免疫使小鼠免于H1N1(PR8)所致疾病,并产生病毒特异性记忆T细胞。
- 初次感染后35天再次攻击PR8时,IgY抗H5N1处理小鼠获得完全保护。
- 感染后3个月以异型H3N2(X-31)或PR8攻击时,小鼠免受严重疾病和死亡,仅见轻度一过性体重下降。
核心结论
- IgY抗H5N1被动免疫安全,可保护小鼠免于流感病毒诱导的疾病,且不抑制病毒暴露后保护性免疫的形成。
- 被动免疫可与免疫接种联合用于预防疾病。
研究设计与样本
- 动物实验:成年或老年、雌雄C57BL/6NCrl小鼠经鼻给予鸡IgY抗H5N1、正常IgY或PBS,分别在经鼻感染H1N1流感病毒(PR8)前4小时和感染后20小时给药。
主要发现
- 接受交叉反应性IgY抗H5N1的小鼠受到保护、未发病,并产生与对照处理小鼠相似的流感病毒特异性记忆T细胞。
- 初次感染后35天再次攻击PR8时,IgY抗H5N1处理小鼠获得完全保护。
- 感染后3个月以异型H3N2(X-31)或PR8攻击时,小鼠免受严重疾病和死亡,但见轻度一过性体重下降。
临床怎么用
- 作者认为,被动免疫可作为预防性治疗与免疫接种联合用于预防疾病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Influenza virus contributes substantially to the global human and animal disease burden. To protect individuals against disease, strategies are needed to minimize the time an individual is at risk of developing disease symptoms. Passive immunization using avian IgY antibodies can protect individuals against a variety of pathogens, including influenza virus. Yet the effect of IgY administration on generation of protective immunity is largely unknown. To address the effect of passive immunization on the host immune response development, adult or aged, male and female C57BL/6NCrl mice received chicken IgY anti-H5N1, normal IgY or PBS intranasally four hours before, and 20 hours after intranasal infection with H1N1 influenza A virus (PR8). The mice receiving cross-reactive IgY anti-H5N1 were protected from disease and developed influenza virus-specific memory T cells similar to control-treated mice. When re-challenged with PR8 35 days post primary infection IgY anti-H5N1-treated mice were fully protected. Moreover, when challenged with heterologous H3N2 influenza A virus (X-31) or with PR8 three months post infection the mice were protected against severe disease and death, albeit a slight transient weight loss was noted. The results show that passive immunization with IgY anti-H5N1 is safe and protects mice against disease induced by influenza virus without inhibiting development of protective immunity after virus exposure. This indicate that passive immunization can be used as prophylactic therapy in combination with immunization to prevent disease.
引用
- Eriksson M, Nylén S, Grönvik KO, et al. Passive immunization of mice with IgY anti-H5N1 protects against experimental influenza virus infection and allows development of protective immunity. Vaccine. 2024. PMID: 39019655. doi:10.1016/j.vaccine.2024.07.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。